Abstract 2904: Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis: Results from the Dallas Heart Study
2006
Background: Pro-inflammatory interleukin (IL)-18 promotes atherogenesis in animals and predicts cardiovascular risk in humans. We investigated whether IL-18 plasma levels associate with the metabol...
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI